References
- Katz L A, Spiro HM. Gastrointestinal manifestations of diabetes. N Engl J Med 1966; 275: 1350–61
- Battle W M, Snape W P, Alavi A, Cohen S, Braunstein S. Colonic dysfunction in diabetes mellitus. Gastroenterology 1980; 79: 1217–21
- Liu H S, Karakioa T, Hemma S. Acetylcholine and substance P responsiveness of intestinal smooth muscles in streptozotocin diabetic rats. Jpn J Physiol 1988; 38: 787–97
- Belai A, Lincoln P, Burnstock G. Progressive changes in adrenergic, serotonergic, and peptidergic nerves in proximal colon of streptozotocin-diabetic rats. Gastroenterology 1988; 95: 1234–41
- Goldin E, Karmeli F, Selinger Z, Rachmilewitz D. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 1989; 34: 754–7
- National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039–52
- Bartho L, Holzer P. Search for a physiological role of substance P in gastrointestinal motility. Euroscience 1985; 16: 1–32
- Llewellyn-Smith I J, Furness J B, Murphy R, Obrien P E, Costa M. Substance P-containing nerves in the human small intestine. Gastroenterology 1984; 86: 421–35
- Bradin E, Sjolund K, Hakanson R, Sundler F. Substance P-containing nerve fibers are numerous in humans but not in feline intestinal mucosa. Gastroenterology 1983; 85: 557–64
- Martenson H G, Alkande B, Yep C H, Jaffe BM. The role of substance P in the control of gastric acid secretion. Surgery 1984; 454: 567–71
- Konturek S J, Jaworek J, Tasler J, Cieszdowski M, Pawlik W. Effect of substance P and its C-terminal hexopeptide on gastric and pancreatic secretion in dog. Am J Physiol 1981; 214: 674–81
- McFadden D, Zinner M J, Jaffe BM. Substance P-induced interstitial secretion of water and electrolytes. Gut 1986; 27: 267–72
- Silkoff P, Karmeli F, Goldin E, et al. Effect of substance PP in rat gastrointestinal transit. Dig Dis Sci 1988; 33: 74–7
- Donnerer J, Bartho L, Holtzer P, Lembeck E. Intestinal peristalsis associated with release of immunoreactive substance P. Neuroscience 1984; 11: 913–8
- Long R G, Barnes A J, O'Shaughnessy D J, et al. Neural and hormonal peptides in rectal biopsy specimens from patients with Chagas' disease and chronic autonomic failure. Lancet 1980; 1: 559–62
- Powel D, Cannon P, Skrabanek P, Kirrane J. The pathophysiology of substance P in man. Gut hormones, S R Bloom. Churchill Livingstone, Edinburgh 1978; 525–9
- Domschke S, Adrian T E, Bloom S R, Lux G, Bryant M G, Domschke W. ViP substance P and gastrin levels of gastro-duodenal mucosa in celiac sprue [abstract]. Gastroenterology 1982; 82: 1044
- Walsh JH. Gastrointestinal peptide hormones. Gastrointestinal disease.4th ed., M Schlesinger, J S Fordtran. WB Saunders, Philadelphia 1983; 78
- Mitsukawa T, Takemura J, Ohgo S, et al. Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol 1990; 85: 981–5
- Winocour P H, Limiuk P, Grennan A, Baker R D, Weinkove C. Platelet and plasma vasoactive amines in type 1 insulin-dependent diabetes mellitus with and without vascular disease. Ann Clin Biochem 1990; 27: 238–43
- Schmidt H, Riemann J F, Schmidt A, Sailer D. Ultrastructure of diabetic autonomic neuropathy of the gastrointestinal tract. Klin Wochenschr 1984; 62: 399
- Monckton G, Pekowitch E. Autonomic neuropathy in streptozotocin-induced diabetes in rats. Can J Neurol Sci 1980; 7: 135